General description

Trousseau syndrome is a condition characterized by hypercoagulability associated with an underlying malignancy, often manifesting as thromboembolic events, including stroke. It can precede or occur alongside the diagnosis of the malignancy. The syndrome encompasses a range of thrombotic phenomena, including migratory venous thrombophlebitis, arterial and venous thromboembolism, and vascular complications of non-bacterial thrombotic endocarditis, all driven by cancer-related hypercoagulability.

Trousseau syndrome is commonly associated with malignancies such as lung, gastrointestinal, kidney, prostate, breast, uterine, and hematologic cancers. Early recognition of thrombotic events in the context of hypercoagulability is crucial, as they may serve as a marker for occult malignancy.